Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,871 total articles
Nautilus Biotechnology reported its Q1 2026 financial results showing a reduced net loss of $14.7 million compared to $16.6 million in the same period last year, alongside a 14% decrease in operating expenses. The company progressed towards commercializing its single-molecule proteome analysis platform by initiating an Early Access Program and appo…
Eva Live Inc. (NASDAQ: GOAI) announced the launch of Eva Brain, an autonomous AI marketing agent that automates campaign management across multiple platforms without human intervention. This innovation aims to improve ad efficiency, reduce costs, and disrupt traditional advertising agencies. The company reported strong financial results with an 82.…
Central Bancompany, Inc. reported strong financial performance for Q1 2026, with GAAP net income rising 17% year-over-year to $111.1 million, driven by loan and deposit growth and improved operational efficiency. The company increased its quarterly dividend by 118% and repurchased shares, reflecting confidence in its financial position and outlook.
AmpliTech Group, Inc., a designer and manufacturer of advanced RF microwave components and 5G network solutions, announced over $2 million in follow-on orders under a previously announced Letter of Intent with a North American mobile network operator. These incremental orders exceed original expectations, boosting the company's backlog to over $20 …
Kaltura, Inc. has introduced an AI-native integration for its Kaltura Events Platform allowing organizations to create and manage virtual events entirely via natural language conversation with AI assistants. This breakthrough leverages the Model Context Protocol to enable seamless event orchestration, enhancing productivity by simplifying complex v…
VisionWave Holdings, Inc. announced the filing of a provisional patent application for its xCalibre™ visual intelligence platform, a next-generation AI architecture that transforms various camera streams into intelligent sensor data capable of detection, classification, threat analysis, and operational alerts. This technology aims to improve real-t…
BioCardia announced the allowance of a Japanese patent for its proprietary Heart3D fusion imaging software designed to enhance procedure planning and real-time navigation during CardiAMP cell therapy for ischemic heart failure. The company is preparing regulatory submissions in Japan following positive consultations and anticipates similar discussi…
Solid Biosciences announced that the European Commission has granted orphan drug designation to its investigational gene therapy SGT-003 for the treatment of Duchenne muscular dystrophy. This designation complements previous regulatory recognitions and supports the company's global development efforts, including ongoing Phase 1/2 and Phase 3 clinic…
Amesite Inc. has entered into a private placement agreement with company insiders to raise approximately $600,000 by selling common stock and warrants priced at a premium to market. This follows a concurrent registered direct offering and aims to help the company regain compliance with Nasdaq's minimum stockholder equity requirements, with total gr…
Cabaletta Bio and Cellares have entered a 10-year commercial supply agreement to leverage Cellares' automated Cell Shuttle and Cell Q platforms for the industrial manufacturing of rese-cel, a CAR T cell therapy targeting autoimmune diseases. This partnership aims to enable flexible, scalable, and cost-efficient production to supply thousands of pat…
Aterian, Inc. announced a definitive agreement to sell its marquee e-commerce brand portfolio to Trademark Global for $18 million, subject to adjustments, and a separate $7 million strategic investment via convertible preferred stock by David Lazar, who will become CEO after closing. The sale requires stockholder approval and is expected to close i…
Annovis Bio released peer-reviewed Phase 2/3 trial data of their oral therapy buntanetap in mild to moderate Alzheimer's disease patients. The drug demonstrated dose-dependent cognitive improvements, reduced neurotoxic and neuroinflammation biomarkers, and was safe and well-tolerated, including in genetically at-risk ApoE4 carriers. These results s…
California BanCorp reported net income of $13.8 million ($0.42 per diluted share) for the first quarter of 2026, down from $16.4 million in Q4 2025. The company highlighted benefits from a merger driving a statewide footprint in California's key markets. Despite a slight increase in net interest margin to 4.47%, the company experienced a decrease i…
BIO-key International, Inc. announced a 1-for-10 reverse stock split effective April 30, 2026, approved by stockholders to help meet Nasdaq's minimum bid price requirements. The company aims to position its stock for compliance while targeting profitability in the first half of 2026. BIO-key develops biometric identity and access management solutio…
Nexera Technologies Ltd announced that its subsidiary KeepZone AI has received official authorization from a protective infrastructure provider to introduce and represent an advanced composite structural survivability system for fuel storage tanks and critical energy infrastructure in the Gulf. This system enhances blast mitigation, fragmentation p…
InflaRx N.V., a biopharmaceutical company focused on anti-inflammatory therapies, has announced that it has regained compliance with Nasdaq's minimum bid price requirement after its ordinary shares closed at or above $1.00 for 10 consecutive business days. This compliance removes the risk of delisting and bolsters confidence in the company's stock.
Watsco, Inc., the largest North American HVAC/R distributor, announced a definitive agreement to acquire Jackson Supply Company, a leading HVAC distributor in the Sunbelt region with $230 million in revenue and 25 locations. The acquisition is expected to close in Q2 2026, enhancing Watsco's scale in high-growth markets and leveraging technology pl…
ZenaTech, Inc. (Nasdaq: ZENA) announced that its subsidiary ZenaDrone will showcase its most comprehensive defense-focused drone hardware, software, and Drone as a Service (DaaS) at the AUVSI Xponential 2026 conference in Detroit. The company will engage defense, government, and enterprise stakeholders with live demonstrations, a podcast studio, an…
Harvard Bioscience, a life sciences technology developer, declared that it will release quarterly financial results for Q1 2026 on May 12 before market open and host a conference call to discuss these results. The company provides technologies and services supporting research and pharmaceutical development globally, with operations in the US, Europ…
NorthStrive Biosciences Inc., a subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), announced the filing of a new US patent application covering the development of EL-22, a myostatin-engineered probiotic technology, for pharmaceutical use targeting muscle loss conditions in humans. The patent includes protection for specific dosing regimens and formul…
Streamex Corp. (NASDAQ: STEX) announced the first yield distribution for GLDY, a gold-backed, yield-bearing tokenized security. The yield, generated through a gold leasing program with an annualized lease yield of 3.5%, is distributed in additional GLDY tokens monthly. This milestone validates Streamex's infrastructure and product, bridging traditi…
Watsco, Inc., the leading North American HVAC distributor, reported flat first quarter 2026 revenues and earnings, reflecting market stabilization following the A2L refrigerant transition. The company announced the pending acquisition of Jackson Supply Company, enhancing scale and diversification in its core Sunbelt markets. Watsco continues to inv…
Helus Pharma has partnered with mental health organization TARA Mind to support recruitment for its Phase 3 clinical trial of HLP003, a novel serotonergic agonist for major depressive disorder, specifically targeting veterans. This collaboration aligns with a recent U.S. Executive Order focusing on accelerating treatments for serious mental illness…
BridgeBio Pharma initiates a national educational campaign highlighting ATTR-CM, a frequently overlooked heart condition, to encourage earlier diagnosis and treatment. The campaign features advocates Morgan Freeman and Howard H. White and promotes their drug, Attruby®, which showed significant clinical benefits in reducing cardiovascular-related ho…
FTI Consulting's economic consulting arm, Compass Lexecon, has announced the affiliation of Dr. Ori Heffetz, a prominent behavioral and experimental economist with distinguished academic credentials. Dr. Heffetz brings expertise in applied economics, behavioral research, survey methodology, and experimental economics, aligning with Compass Lexecon'…
